Valuation : Photocure ASA

Market Cap 1.45B 156M 134M 126M 115M 215M 14.76B 217M 1.49B 581M 7.54B 586M 574M 24.29B P/E 2026 *
19x
P/E 2027 * 69.1x
Enterprise Value 1.28B 138M 119M 111M 102M 190M 13.04B 192M 1.32B 513M 6.66B 518M 507M 21.46B EV / Sales 2026 *
1.95x
EV / Sales 2027 * 1.94x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+0.19%
1 week-3.23%
Current month-0.92%
1 month+12.27%
3 months-11.33%
6 months-23.84%
Current year-24.37%
1 week 52.7
Extreme 52.7
56.8
1 month 48.2
Extreme 48.2
60.5
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 41.7
Extreme 41.7
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 31/10/2018
Chief Tech/Sci/R&D Officer - 31/07/2021
Human Resources Officer - 31/01/2021
Director TitleAgeSince
Director/Board Member - 31/12/2021
Chairman - 26/09/2023
Director/Board Member - 22/05/2024
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/25 BuyCompany 11,355 0.0419%
02/04/25 BuyCompany 8,997 0.0332%
31/03/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
+0.19%-3.23%-11.76%+14.65% 156M
-0.04%-1.40%+57.16%+108.15% 1,034B
+1.17%+4.76%+56.42%+73.50% 671B
-0.58%+0.80%+22.82%+75.58% 460B
-0.56%-0.98%+28.84%+37.86% 353B
-1.17%+5.08%+25.12%+46.04% 309B
+0.12%+1.74%-0.08%+13.92% 255B
+0.29%+1.63%+56.46%+73.00% 240B
-0.75%+1.39%-16.89%-54.29% 207B
+1.08%+1.59%+33.83%+97.29% 188B
Average -0.24%+0.74%+25.19%+48.57% 371.69B
Weighted average by Cap. -0.40%+1.04%+38.14%+67.67%

Financials

2026 *2027 *
Net sales 658M 70.85M 60.96M 57.21M 52.34M 97.69M 6.7B 98.47M 677M 264M 3.42B 266M 260M 11.02B 666M 71.71M 61.7M 57.9M 52.98M 98.88M 6.78B 99.66M 685M 267M 3.46B 269M 263M 11.16B
Net income 76.33M 8.22M 7.07M 6.63M 6.07M 11.33M 777M 11.42M 78.47M 30.56M 397M 30.85M 30.18M 1.28B 21M 2.26M 1.94M 1.82M 1.67M 3.12M 214M 3.14M 21.59M 8.41M 109M 8.49M 8.3M 352M
Net Debt -169M -18.19M -15.65M -14.69M -13.44M -25.08M -1.72B -25.28M -174M -67.66M -879M -68.3M -66.81M -2.83B -157M -16.9M -14.54M -13.64M -12.48M -23.3M -1.6B -23.48M -161M -62.85M -816M -63.45M -62.07M -2.63B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
04/09/26 NOK 54.00 +0.19% 12,013
03/09/26 NOK 53.90 +0.75% 21,162
02/09/26 NOK 53.50 -0.56% 97,323
01/09/26 NOK 53.80 -1.28% 38,116
31/08/26 NOK 54.50 -2.33% 62,650
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
53.90NOK
Average target price
79.67NOK
Spread / Average Target
+47.80%

Quarterly revenue - Rate of surprise